Exact Sciences Overview
Valuation check: EXAS's PEG ratio is 106.26, above the Healthcare sector average of 11.64.
Get informed when a big investor buys or sells
+ Follow106.26
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Exact Sciences (EXAS) currently reports a PEG ratio of 106.26. That is above the Healthcare sector average of 11.64. Use the charts on this page to explore Exact Sciences's PEG ratio history and peer comparisons.
Exact Sciences's PEG ratio of 106.26 is higher than the Healthcare sector average of 11.64. That is roughly 812.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Exact Sciences's market price to a fundamental measure such as earnings, sales, or book value. At 106.26, EXAS can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of 106.26, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.64. From there, open related valuation or income-statement pages for Exact Sciences, and consider following EXAS for alerts when major investors trade the stock.
Exact Sciences is classified in the Healthcare sector. On PEG ratio, it currently shows 106.26 versus a sector average near 11.64. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EXAS with unrelated industries.
